Home/Filings/4/0001209191-21-027683
4//SEC Filing

KENYON LAWRENCE A 4

Accession 0001209191-21-027683

CIK 0001649989other

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 7:54 PM ET

Size

5.2 KB

Accession

0001209191-21-027683

Insider Transaction Report

Form 4
Period: 2021-04-20
KENYON LAWRENCE A
CFO and Secretary
Transactions
  • Purchase

    Common Stock

    2021-04-20$1.83/sh+10,000$18,30018,926 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within a $1.00 range. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Issuer

Outlook Therapeutics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1
  • filerCIK 0001230484

Filing Metadata

Form type
4
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 7:54 PM ET
Size
5.2 KB